Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_assertion type Assertion NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_head.
- NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_assertion description "[We also demonstrated that CDK4 and CDK6 are direct targets of miR-506, and that miR-506 can inhibit CDK4/6-FOXM1 signalling, which is activated in the majority of serous ovarian carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_provenance.
- NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_assertion evidence source_evidence_literature NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_provenance.
- NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_assertion SIO_000772 24604117 NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_provenance.
- NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_assertion wasDerivedFrom befree-20150227 NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_provenance.
- NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_assertion wasGeneratedBy ECO_0000203 NP301368.RAZoWx90Qm4B3pT79hHGVqejjwmKkurjK69WHgIl9WAgQ130_provenance.